VSTM vs. CRDF
VSTM (Verastem, Inc.) and CRDF (Cardiff Oncology, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, VSTM returned -12.26%/yr vs -42.47%/yr for CRDF. At a 0.26 correlation, their price movements are largely independent.
Performance
VSTM vs. CRDF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VSTM achieves a -44.95% return, which is significantly higher than CRDF's -53.74% return. Over the past 10 years, VSTM has outperformed CRDF with an annualized return of -12.26%, while CRDF has yielded a comparatively lower -42.47% annualized return.
VSTM
- 1D
- 3.16%
- 1M
- 0.24%
- YTD
- -44.95%
- 6M
- -46.20%
- 1Y
- -13.79%
- 3Y*
- -21.45%
- 5Y*
- -39.19%
- 10Y*
- -12.26%
CRDF
- 1D
- 7.44%
- 1M
- -26.97%
- YTD
- -53.74%
- 6M
- -55.48%
- 1Y
- -58.06%
- 3Y*
- -4.01%
- 5Y*
- -29.32%
- 10Y*
- -42.47%
VSTM vs. CRDF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VSTM Verastem, Inc. | -44.95% | 49.32% | -36.49% | 68.53% | -80.37% | -3.76% | 58.96% | -60.12% | 9.45% | 174.11% |
CRDF Cardiff Oncology, Inc. | -53.74% | -35.25% | 193.24% | 5.71% | -76.71% | -66.59% | 1,350.81% | -60.67% | -85.76% | -85.36% |
Correlation
The correlation between VSTM and CRDF is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 27, 2012 | 0.26 |
Fundamentals
VSTM:
$421.38M
CRDF:
$88.86M
VSTM:
-$2.35
CRDF:
-$0.67
VSTM:
7.07
CRDF:
180.36
VSTM:
$49.59M
CRDF:
$484.00K
VSTM:
$25.91M
CRDF:
-$11.32M
VSTM:
-$209.89M
CRDF:
-$45.29M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VSTM vs. CRDF — Risk / Return Rank
VSTM
CRDF
VSTM vs. CRDF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Verastem, Inc. (VSTM) and Cardiff Oncology, Inc. (CRDF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VSTM | CRDF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +1.03 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.90 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.21 | -0.79 | +0.58 |
| Martin ratioReturn relative to average drawdown | -0.39 | -1.12 | +0.73 |
Loading charts...
Drawdowns
VSTM vs. CRDF - Drawdown Comparison
The maximum VSTM drawdown since its inception was -98.96%, roughly equal to the maximum CRDF drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for VSTM and CRDF.
Loading charts...
Drawdown Indicators
| VSTM | CRDF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.96% | -99.96% | +1.00% |
Max Drawdown (1Y)Largest decline over 1 year | -66.39% | -73.48% | +7.09% |
Max Drawdown (3Y)Largest decline over 3 years | -84.36% | -80.03% | -4.33% |
Max Drawdown (5Y)Largest decline over 5 years | -95.86% | -87.80% | -8.06% |
Max Drawdown (10Y)Largest decline over 10 years | -98.16% | -99.82% | +1.66% |
Current DrawdownCurrent decline from peak | -97.98% | -99.93% | +1.95% |
Average DrawdownAverage peak-to-trough decline | -75.32% | -86.22% | +10.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.07% | 51.71% | -16.64% |
Volatility
VSTM vs. CRDF - Volatility Comparison
The current volatility for Verastem, Inc. (VSTM) is 17.79%, while Cardiff Oncology, Inc. (CRDF) has a volatility of 36.54%. This indicates that VSTM experiences smaller price fluctuations and is considered to be less risky than CRDF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VSTM | CRDF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.79% | 36.54% | -18.75% |
Volatility (6M)Calculated over the trailing 6-month period | 47.73% | 71.07% | -23.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.41% | 84.80% | -7.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.69% | 100.14% | +5.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.39% | 105.77% | -8.38% |
Dividends
VSTM vs. CRDF - Dividend Comparison
Neither VSTM nor CRDF has paid dividends to shareholders.
Financials
VSTM vs. CRDF - Financials Comparison
This section allows you to compare key financial metrics between Verastem, Inc. and Cardiff Oncology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VSTM and CRDF have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRDF has higher volatility (36.54%) compared to VSTM (17.79%). In terms of maximum drawdown, VSTM dropped -98.96% vs CRDF's -99.96%.
VSTM currently has the higher Sharpe Ratio (-0.18 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VSTM and CRDF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer